Stansberry Asset Management’s Teladoc Health TDOC Stock Holding History

Stansberry Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,633	Closed	-$346K	–	119
2023 Q3	$346K	Buy	18,633 +1,724	+10%	+$40.2K	0.06%	104
2023 Q2	$428K	Buy	16,909 +157	+0.9%	+$3.95K	0.08%	90
2023 Q1	$434K	Sell	16,752 -704	-4%	-$18.8K	0.08%	92
2022 Q4	$565K	Buy	17,456 +1,476	+9%	+$39.8K	0.12%	86
2022 Q3	$405K	Sell	15,980 -389	-2%	-$13.6K	0.09%	91
2022 Q2	$544K	Sell	16,369 -296	-2%	-$12.6K	0.12%	89
2022 Q1	$1.2M	Buy	16,665 +790	+5%	+$56.9K	0.2%	71
2021 Q4	$1.46M	Buy	15,875 +9,501	+149%	+$1.14M	0.23%	54
2021 Q3	$808K	Buy	+6,374	New	+$928K	0.16%	50

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stansberry Asset Management's TDOC Position: Q4 2023 in Review

Stansberry Asset Management sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 18,633 shares — an estimated $346K sold.

Stansberry Asset Management first reported a position in TDOC in Q3 2021 and held it in 9 quarters. The position peaked at $1.46M in Q4 2021. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

Stansberry Asset Management reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
Stansberry Asset Management sold 18,633 Teladoc Health shares in Q4 2023, an estimated $346K.
Stansberry Asset Management first reported a position in Teladoc Health in Q3 2021 and held it in 9 quarters.
Stansberry Asset Management's Teladoc Health position peaked at $1.46M in Q4 2021.
435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Stansberry Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.